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Abstract: The goal of the research work entertained herein was the development and characterization of a poly-(vinyl al-
cohol) (PVA) hydrogel cross-linked with glutaraldehyde and impregnated with 0.2% (w/w) nitrofurazone (NTZ), for topi-
cal applications. To verify the active principle release capability, one has determined (i) swelling profile, (ii) in vitro re-
lease of NTZ via UV-VIS spectrophotometry, and (iii) antimicrobial activity via exposure to the hydrogel of ATCC 
strains of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. The optimized hydrogel was further 
characterized via scanning electron microscopy (SEM), infrared spectroscopy with Fourier transform, moisture content 
determinations and thermal analyses via thermal gravimetry (TGA). Swelling tests revealed a mass increase from 100±5% 
up to 350±11%. Incorporated NTZ displayed bactericidal activity, as expected, being released in a linearly controlled 
fashion above 6 µg/mL during experiment timeframes of 14 h. SEM analyses allowed verification of a homogeneous sur-
face morphology, while infrared spectra showed that NTZ did not bind strongly to the cross-linked polymer. Furthermore, 
results from thermal analyses suggested a loss of thermal stability arising from incorporation of NTZ in the hydrogel. The 
optimized hydrogel exhibited characteristics with high potential for (antimicrobial) treatment of skin lesions. 
Keywords: Antimicrobial, controlled drug release systems, hydrogel, nitrofurazone, topical applications. 
1. INTRODUCTION 
 Systems for the modified release of pharmaceuticals have 
been developed over the last few years aiming at reducing 
the frequency of administration, and increase both tolerance 
and compliance to the treatment by the patient. Among the 
several pharmaceutical formulations developed as modified 
release systems, gels and hydrogels may be considered con-
trolled release systems for pharmaceuticals intended for topi-
cal applications, depending on both the type of formulation 
and intended use application [1, 2]. The topical route consti-
tutes an interesting alternative for the administration of 
pharmaceuticals, due to factors such as high patient compli-
ance rates and ease of interruption of the administration  
[3, 4]. 
 Hydrogels or hydrocolloids are three-dimensional net-
works formed by long-chain polymers, of vegetal or animal, 
synthetic or microbial, synthesis. These polymers swell upon 
contact with water, but maintain their structural integrity [5]. 
Gels and hydrogels, depending on their rheological and 
bioadhesive behavior, may adhere to the surface of applica-
tion for long periods of time, allowing the extended release 
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in time of the drug in the site of application, with clear ad-
vantages in terms of ease of application and/or removal. 
Hence, hydrogels are particularly interesting in the treatment 
of topical wounds due to their intrinsic low toxicity, potential 
for extended release of drugs, and characteristics of bioadhe-
siveness [6-8]. Additionally, hydrogels have been success-
fully used to develop oral, rectal, ocular, transdermal and 
implantable drug delivery systems [9-11]. Poly-(vinyl alco-
hol) (or PVA, for short) has been used in gels, hydrogels and 
polymeric films carrying drugs, owing to their properties of 
(bio)degradability and lack of toxicity, being considered bio-
compatible with living tissues in general and even with 
plasmatic proteins [12-15]. 
 Hydrogels can be obtained by chemical cross-linking, 
aiming at modifying the properties linked to both chemical 
and thermal stability, structural rigidity, permeability, color, 
chelating efficiency and capability for both protein and cell 
immobilization [16]. Cross-linking consists in a type of 
modification aiming at joining polymeric chains, or even 
linking its chains to the ones of other types of polymers thus 
generating hybrid polymeric networks, produced via reac-
tions between specific reactive sites present in the structural 
units of the polymer and certain cross-linking reagents  
[17, 18]. 
 Nitrofurazone (NTZ) (among other active substances) 
can be used for the treatment of skin lesions. NTZ is used as 
topical formulations for administration of antimicrobial 
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agents, as creams, gels and ointments in the treatment of 
infected wounds from traumatisms, burns or surgical inter-
ventions [19]. NTZ is also effective in the treatment of 
wounds infected by significant pathogenic bacteria such as 
Staphylococcus aureus (including Methicillin-Resistant 
Staphylococcus aureus (MRSA) strains) and Streptococcus 
[20]. 
 In Brazil, quite recent estimates point to ca. 11.3 million 
inhabitants presenting some type of complications in the 
process of scar/healing and, of these, ca. 4 million carry 
cronic lesions [21]. These numbers justify per se the search 
for new resources and technologies, with lower costs and 
higher efficiencies. Therefore, the major goal of the research 
effort presented herein was to develop and fully characterize 
a PVA hydrogel with nitrofurazone incorporated at 0.2% 
(w/w) in its three-dimensional network, using glutaraldehyde 
as cross-linking reagent, for topical applications. 
2. MATERIAL AND METHODS 
2.1. Reagents 
 98.4% hydrolyzed polyvinyl alcohol (PVA) with a mo-
lecular weight between 146000-186000 g/mol was obtained 
from Vetec (Duque de Caxias/RJ, Brazil). Glutaraldehyde at 
25% (v/v) was from Sigma-Aldrich (St. Louis MO, U.S.A.). 
Nitrofurazone (C.A.S. 59-87-0), 97.3% pure in an anhydrous 
base, was kindly gifted by Henrifarma Produtos Químicos e 
Farmacêuticos Ltda. (São Paulo/SP, Brazil). All other rea-
gents were of PA grade or better, and the water used was 
purified in a Milli-Q Plus 185 system (Molsheim, France) to 
a final conductivity of ca. 18.2 MΩ•cm-1. The culture media 
used were Müeller-Hinton Agar, MacConkey Agar, Blood 
Agar (supplemented at the time of preparation with 5% 
ram’s defibrinated blood) and Tryptic Soy Agar, and were all 
purchased from Oxoid (Basingstoke, United Kingdom). The 
commercial nitrofurazone disc used as reference was Sensi-
far® (containing 300 µg active nitrofurazone) from CEFAR 
(Brazil). 
2.2. Biological Material 
 The microbial strains used were a kind gift from the Mi-
crobiology Laboratory of UBM (University Centre of Barra 
Mansa/RJ, Brazil), consisting in a strain of Escherichia coli 
(ATCC 25922, beta-lactamase negative), a strain of Pseudo-
monas aeruginosa (ATCC 27853), and a strain of Staphylo-
coccus aureus (ATCC 250923, susceptible to oxacillin and 
penicillin). 
2.3. Experimental Procedures 
2.3.1. Preparation of the Hydrogel with Incorporated Nitro-
furazone 
 The first step in formulating the hydrogel consisted in the 
preparation of an aqueous dispersion of PVA at 10% (w/v). 
For dissolution, the dispersion thus obtained was kept under 
strong magnetic stirring (about 300 rpm) at 80°C±5ºC during 
25 min (in a magnetic stirrer from Fisatom, model 78HW-1, 
São Paulo/SP, Brazil), after which it was immersed in a wa-
ter bath (Unique, model Ultra Cleaner, Indaiatuba/SP, Bra-
zil) thermostatted at 40 °C and subject to ultrasounds during 
30 min for elimination of remaining air bubbles resulting 
from magnetic stirring. After this time period (30 min), the 
dispersion was allowed to stand still during ca. 20 min until 
reaching room temperature (± 25°C). The cross-linking reac-
tion was then initiated via addition of an aqueous solution of 
glutaraldehyde (at 25 %, v/v). The pH was carefully adjusted 
to 6.00±0.05 using 0.5 M HCl [22]. For incorporation of the 
active antimicrobial agent (NTZ), dissolution of NTZ in 
polyethylene glycol (0.2% (w/v)) was carried out prior to 
being added to the cross-linked PVA dispersion. The result-
ing solution was poured into plastic moulds and, for evapora-
tion of the solvent, these were placed in an incubating cham-
ber at 60ºC (from Fanem, model 515-A, Guarulhos/SP, Bra-
zil) during ca. 2 h, until constant weight. The final hydrogel 
thus obtained presented a mass of ca. 10 g with a concentra-
tion of NTZ of ca. 0.02 g. In this way, a hydrogel with 0.2 % 
(w/w) NTZ was produced, with a similar concentration of 
the ointment and topical solution Furacin®, the commercial 
form of nitrofurazone available in the market [23]. The hy-
drogel films produced were protected from the UV-light via 
wrapping in aluminum foil. 
2.3.2. Evaluation of the degree of swelling of the hydrogel 
 The degree of swelling of the hydrogel film was  
determined according to the methodology described by  
Mansur and colleagues [22], using the equation 
Degree of swelling = M t -M 0( ) M0{ }×100 , where Mt repre-
sents the mass of hydrogel sample swelled after time t, and 
M0 represents the initial mass of dry hydrogel sample (mass 
of±10 g) [24]. With the aid of tweezers, each hydrogel sam-
ple was placed in an individual 250 mL volumetric flask 
with 50 mL of phosphate buffer system (PBS, 0.1 M, pH 
6.00±0.05) and these were maintained at a temperature of 
37°C±0.5 °C. Every 2 h, the mass of the hydrogel samples 
was determined using an analytical scale (from Tecnal, 
model SHI-AUY-220, Piracicaba/SP, Brazil) to assess the 
weight gain by the hydrogel. 
2.3.3. In vitro Release Assays of NTZ from the Hydrogel 
 The in vitro release assays followed the methodology 
described by Murphy and colleagues [8], with NTZ being 
determined via spectrophotometry in the UV range (wave-
length of 375 nm, for a maximum absorption peak of NTZ 
according to Tubino et al. [25]). For determination of the 
concentration of NTZ released from the hydrogels, one has 
prepared a standard calibration curve using several NTZ so-
lutions with concentrations of 0.002, 0.004, 0.006, 0.008 and 
0.010 g/L of NTZ in an aqueous solution of polyethylene 
glycol (at 10%, v/v), with the absorbances read at 375 nm 
(using a UV-VIS spectrophotometer from Hach Lange, 
model DR 5000, Düsseldorf, Germany). Three hydrogel 
samples, previously dried at 60ºC during 2 h, were individu-
ally placed in separate volumetric flasks and added with 50 
mL of phosphate buffer system (PBS, 0.1 M, pH 6.00±0.05). 
The volumetric flasks containing the hydrogel samples were 
duly stoppered to avoid any weight losses by evaporation, 
and were kept at 37°C±0.5°C in the dark. Every 2 h of incu-
bation, the total volume of PBS buffer (50 mL) was with-
drawn from the volumetric flasks and subjected to absor-
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bance readings at 375 nm, using PBS as the blank, since the 
volume of polyethylene glycol used to prepare the hydrogel 
samples was virtually negligible. After every withdrawal of 
PBS (containing NTZ) from the volumetric flasks, a new 50 
mL volume of fresh PBS was again poured into each of the 
volumetric flasks, and this procedure was repeated during a 
total timeframe of 14 h. 
2.3.4. Evaluation of the Antimicrobial Activity Resulting 
from NTZ Release from the Hydrogel in Culture Medium, 
by the Method of Disk-Diffusion 
 NTZ release from the hydrogel was also assessed by a 
microbiological method, using the susceptibility test to an-
timicrobials, namely the disk-diffusion technique according 
to the National Committee of Clinical Laboratory Standards 
[26]. The Escherichia coli and Staphylococcus aureus strains 
were inoculated in TSB (Tryptic Soy Broth) broth which was 
added with 15% glycerol at a temperature of -70°C. The 
Pseudomonas aeruginosa strain was kept in sterile ultrapure 
water, at room temperature. The Escherichia coli and Pseu-
domonas aeruginosa microbial strains were then plated in 
triplicate, both on the selective culture medium MacConkey 
Agar and on the non-selective culture medium Blood Agar, 
and incubated at 37°C±0.5°C during 24 h. The Staphylococ-
cus aureus strain was plated in triplicate on the non-selective 
culture medium Blood Agar and incubated at 37°C during 24 
h in a bacteriological incubator (from Fanem, model 515, 
Guarulhos/SP, Brazil). Following incubation, CFU’s were 
asseptically collected from every strain, and were suspended 
in 5 mL of Müeller-Hinton broth, so as to obtain a turbidity 
corresponding to 0.5 in the McFarland scale, confirmed by 
spectrophotometric absorbance readings at a wavelength of 
625 nm (spectrophotometer from Biospectro, model SP-220, 
Curitiba/PR, Brazil). Following confirmation of the target 
turbidity, inoculation in Petri dishes was performed via sur-
face plating on Müeller-Hinton Agar. As a standard for com-
paring the antimicrobial activity of the pharmaceutical com-
pound (NTZ) released from the hydrogels in the respective 
culture media, a commercial disk containing 300 µg of nitro-
furazone (positive control). Disks of hydrogel containing 
NTZ (sample) and disks of plain hydrogel without NTZ 
(negative control), with 7 mm diameters (similar to the 
commercial counterparts), were prepared via cutting hydro-
gel films with a sterile scalpel. The disks were placed on the 
surface of the agar, keeping a minimum distance of 30 mm 
between them (measured from their centers) and a minimum 
distance of 15 mm from the plate edges, thus preventing any 
superposition of inhibition halos. After 24 h of incubation 
under aerobiosis conditions and at 37°C±0.5°C, reading of 
the Petri dishes was carried out via visual inspection with the 
aid of a caliper rule, using a source of reflected light (in-
verted position) on a black and opaque surface. 
2.3.5. Scanning Electron Microscopy Analyses 
 The surface of the hydrogel films containing NTZ was 
duly observed in a scanning electron microscope (from 
JEOL, model JSM-63660, Tokyo, Japan). Hydrogel samples 
were coated with colloidal gold under vacuum, and placed in 
the microscope chamber. Microphotographs were gathered 
using electron beams with 10 keV energy. 
2.3.6. Moisture Content Analyses via Infrared Heating 
 For determination of the moisture content, a moisture 
analyzer producing infrared heating was used (from GEHAKA, 
model 2000, São Paulo/SP, Brazil), equipped with a pro-
grammable timer, self-calibration and temperature adjusting 
between 50°C and 200°C, and allowing moisture content 
determinations within the range 0.01% - 100%. 
2.3.7. Thermal Analyses via TGA 
 The analytical equipment used for the thermogravimetric 
analyses (TGA) was from TA Instruments (model 2050, 
New Castle, U.S.A.). 
2.3.8. Analyses Via Infrared Spectrophotometry  
 The infrared spectra were gathered in the range of wave-
number from 4000 to 650 cm-1 during 64 scans, with a reso-
lution of 4 cm-1, using an infrared spectrophotometer (Illu-
minat IR II from Smiths, Watfords, England). FT-IR spectra 
were obtained using an infrared microprobe (Illuminat IR, 
model II, from Smiths, Watfords, England), coupled with an 
optical microscope (from Olympus, model BX51, Tokyo, 
Japan). 
3. RESULTS AND DISCUSSION 
 The hydrogels obtained according to the procedures de-
scribed earlier presented characteristics of transparency, ab-
sence of air bubbles and of cracks, flexibility and uniform 
yellowish coloration. A moisture content of 18% was ob-
tained, after drying at 40ºC for 2 h. The low moisture content 
in the hydrogels with impregnated NTZ may indicate storage 
and handling easiness. Polyvinyl alcohol (PVA) was the 
polymer chosen to produce the hydrogels due to several suit-
able intrinsic characteristics, namely (i) a good and quick 
dispersion in water, (ii) mucoadhesiveness, (iii) good swel-
ling characteristics, (iv) increased viscosity in solution, (v) 
ease to mould, (vi) good transparency, (vii) biocompatibility, 
(viii) atoxicity, (ix) hydrophilicity, (x) chemical resistance, 
and (xi) adsorption of proteins [18, 27, 28]. This class of 
polymers also favors a slow release of incorporated com-
pounds, which is highly suitable for the treatment of topical 
wounds [8]. As cross-linking reagent, glutaraldehyde was 
selected since it permits the establishment of highly stable 
and irreversible cross-linked covalent bonds, allowing the 
material to resist to both pH and temperature changes (ther-
morigid materials) in a wide range of values, according to 
Oréfice [18]. 
3.1. Ability of the Hydrogel to Release Nitrofurazone  
in vitro 
 The ability of the hydrogel to release the active NTZ was 
assessed via determination of the swelling profile, via spec-
trophotometric quantification of the drug released in solution 
and also via a microbiological procedure through a suscepti-
bility test to antimicrobials by the disk-diffusion technique. 
Regarding the swelling profile, as can be observed from in-
spection of Table 1, an increase in the mass of 100±5% after 
2 h of incubation was obtained, which was maintained at ca. 
350±11% after the fourth hour of incubation and up to the 
end of the 14-h timeframe of the assays. These results are in 
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close agreement with those reported by Murphy et al. [8] and 
Amaral [29], and indicate that the hydrogel adequately ab-
sorbed the saline (PBS buffer) solution (0.1 M, pH 6.00±0.05) 
and at 37°C±0.5°C. Such swelling capability is required to 
confirm effective polymerization and crosslinking processes, 
which are important phenomena to make the polymeric ma-
trix able to incorporate the drug and produce an effective 
release system [29]. 
Table 1. Evolution of the swelling profile of hydrogel contain-
ing incorporated NTZ. 
Time (h) Sweelled hydrogel weight (Mt, g) Weight gain (%) 
0 10±0.5 0 
2 20±0.5 100±5 
4 35±0.7 350±11 
6 35±0.6 350±12 
8 35±0.6 350±12 
10 35±0.6 350±12 
12 35±0.6 350±12 
14 35±0.6 350±12 
 
 Determination of the concentration of NTZ released from 
the hydrogel was carried out via readings of the absorbances, 
at 375 nm, of the supernatant solutions obtained after every 2 
h of incubation of the hydrogel samples in a saline (PBS 
buffer) solution (0.1 M, pH 6.00±0.05). The concentration 
values were calculated departing from the calibration curve 
prepared as Abs@375nm = ƒ{[NTZ, g / L]} (see Table 2 and 
Fig. 5). The results obtained suggest a linear release of NTZ 
throughout the 14 h timeframe assayed (see table 2), which 
will probably allow to use the hydrogel for long periods of 
time in dressings and/or bandages depending on the pro-
longed release of the drug, thus corroborating the results by 
Murphy et al. [8] and Amaral [29]. 
 To shed light on the release profile of NTZ from the hy-
drogel, and because after the 14 h timeframe of assays the 
hydrogel presented a clear erosion, one decided to apply the 
mathematical models of Higuchi (Q = KH ⋅ t , where Q is 
the cumulative amount of drug release, KH is the Higuchi con-
stant and t is time) and Korsmeyer-Peppas (Qt / Q∞ = KKP ⋅ t
n , 
where Qt is the amount of drug released at time t, Q∞ is the 
total amount of drug in the hydrogel, KKP is the Korsmeyer-
Peppas kinetic constant, n is the diffusion or release expo-
nent, ant t is time) to the drug release data, and in fact NTZ 
release from the hydrogel did not occur by diffusion but by 
erosion of the polymeric matrix instead. This is in fact sup-
ported by the model fittings performed to the experimental 
(cumulative) NTZ release data, which produced a correlation 
coefficient r2=0.92351 for the Higuchi model and a correla-
tion coefficient r2=0.99988 for the Korsmeyer-Peppas model. 
The fittings performed clearly show a poor r2 for the Higuchi 
model and an almost perfect r2 for the Korsmeyer-Peppas 
model. Additionally, the diffusion or release exponent (n) in 
the Korsmeyer-Peppas model produced by fitting the model 
to the NTZ release data was n=0.9695 (in the Korsmeyer-
Peppas drug release model, n=0.45 suggests Fickian diffu-
sion, 0.45<n<0.89 suggests anomalous diffusion or non-
Fickian diffusion, and n≥0.89 suggests erosion of the polym-
eric chain), which clearly suggests that NTZ release occurred 
by a gradual erosion of the polymeric chain. The release re-
sults (see newly added Fig. 5) have thus indicated a continu-
ous liberation within the timeframe assayed, evolving from 
erosion of the polymeric matrix. From inspection of Table 2, 
one can see that the NTZ release profile from the hydrogel 
was relatively homogeneous, allowing one to conclude that 
in liquid medium an offer of constant concentrations of NTZ 
does occur throughout time, at least during the timeframe 
assayed (14 h). This is especially important when one deals 
with antimicrobial activity, since any oscillations of concen-
Table 2. Evolution of the NTZ concentration released from the hydrogel throughout a 14-h timeframe, in a saline (PBS buffer) 
solution (0.1 M, pH 6.00±0.05) [Calibration curve for Absorbance at 375 nm vs. NTZ concentration: Abs = 43.0034 x 
[NTZ, g/L] + 0.04178; r = 0.99543]. 
Time (h) 
Average (n=3) Abs at 
375 nm 
[NTZ], g/L NTZ (g/L) released from the hydrogel 
NTZ released (%) relative to the total 
incorporated in the hydrogel 
0 0.000 0.00000 0.00000 0 
2 0.338 0.00688 0.00688 1.72 
4 0.328 0.00665 0.01353 3.38 
6 0.325 0.00659 0.02012 5.03 
8 0.324 0.00656 0.02668 6.67 
10 0.319 0.00645 0.03313 8.28 
12 0.308 0.00620 0.03933 9.83 
14 0.281 0.00563 0.04496 11.24 
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tration in the biophase have the potential to be correlated 
with the selection of antibiotic-resistant strains. According to 
Yilmaz et al. [30], the minimum inhibitory concentration 
(MIC) of NTZ for the bacterial pathogen strains tested is, 
respectively, 32 µg/mL for Escherichia coli and 4 µg/mL for 
Staphylococcus aureus, while Pseudomonas aeruginosa is 
resistant to NTZ. The (calculated) NTZ concentrations re-
leased from each hydrogel sample were higher than 5 µg/mL 
at all times. Hence the concentration of antimicrobial agent 
released is above the MIC for Staphylococcus aureus, one of 
the major bacterial pathogens responsible for infections in 
topical wounds. The activity of NTZ released from the hy-
drogel was evaluated via the disk-diffusion method (see Fig. 1), 
by measuring the inhibition halo of bacterial growth. For the 
cultures of Escherichia coli and Staphylococcus aureus (see 
Figs. 1i, ii), the results from the measurements of bacterial 
growth inhibition halos with hydrogel disks incorporating 
NTZ were, respectively, of 18 and 21 mm. The diameters of 
reference inhibition halos, according to CLSI [26], must be 
higher than 17 mm. Therefore, our results clearly demon-
strate that the bactericidal activity of NTZ against E. coli and 
S. aureus was not modified due to being released from the 
hydrogel. For the Pseudomonas aeruginosa strain (see Fig. 
1iii) one did not detect any growth inhibition, evidenced by 
the absence of inhibition halo in all hydrogel disks, which 
can be ascribed to its natural resistance to NTZ, according to 
Yilmaz et al. [30]. The agar diffusion method relies on the 
diffusion of the compound tested through water-containing 
agar medium. The diffusion of the drug is dependent upon 
the size, shape and polarity of the antibacterial material; 
chemical structure and the cross-linking level of the ﬁlm 
[31]. Thus, it was important to confirm the antimicrobial 
properties of the newly developed hydrogel. 
3.2. Physico-chemical Characterization of the Hydrogel 
 The surface morphology of the hydrogels produced was 
further analyzed by scanning electron microscopy (see Fig. 2). 
One can easily realize from inspection of Fig. 2 that the hy-
drogel matrices produced exhibited an uniform morphology. 
Such surface structure facilitates solvation and dissolution 
upon contact with the solvent. Thus, upon contact with the 
moisture from the skin, especially with the characteristic 
tissue discontinuity observed in wounds, the hydrogel pro-
duced by us may allow the release of its incorporated (ac-
tive) NTZ. 
 
  
Fig. (2). Scanning electron microphotograph of the surface of the 
mucoadhesive polymeric film incorporating NTZ (magnification: 
x100). 
 
 
 
Fig. (1). Macroscopic evaluation of the susceptibility test to nitrofurazone of (i) Escherichia coli ATCC 25922, (ii) Staphylococcus aureus 
ATCC 25083, and (iii) Pseudomonas aeruginosa ATCC 27853 ([a]: hydrogel disk of clPVA/Glut-NTZ; [b]: commercial NTZ disk; [c]: 
hydrogel disk of clPVA/Glut). 
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 The infrared spectra produced for plain nitrofurazone and 
for both plain hydrogels and hydrogels with NTZ incorpo-
rated are displayed in (Figs. 3a1, 3b1 and 3c1), respectively, 
and their magnifications (x36) displayed in (Figs. 3a2, 3b2 
and 3c2), respectively. Infrared spectra of nitrofurazone was 
compared with the one for (standard) orcein dye, and the 
infrared spectra of hydrogels without (clPVA/Glut) and with 
(clPVA/Glut-NTZ) nitrofurazone were compared with that 
for hydrolyzed PVA. A careful inspection of (Fig. 3) may 
indicate that interaction between PVA and glutaraldehyde 
did occur. From comparison between the bands within 3550-
3200 cm-1 of the grouping (OH)OH...OH of intermolecular 
and intramolecular hydrogen bonds, one can notice a de-
crease of intensity which indicates a possible formation of 
acetal bridges. PVA presents another characteristic band at 
2800-2695 cm-1 from CH of aldehyde, which suffers inter-
ference after crosslinking with glutaraldehyde [22]. The 
other bands in 1461-1417 cm-1 of the grouping (CH)-CH2 
and in 1366 cm-1 of the grouping CH-R-CH2 also displayed a 
decrease of intensity and may indicate bonding with glu-
taraldehyde. Comparison between (Figs. 3b1 and 3c1) (infra-
red spectra of hydrogel without and with NTZ, respectively) 
shows no peak displacement at all, being comparable with 
the one from NTZ alone (see Fig. 3a1). The spectrum profile 
was fully conserved, which can most likely mean that NTZ 
virtually does not undergo interaction with the polymer upon 
its incorporation in the hydrogel, just being carried by the 
hydrogel system, which is in close agreement with the linear 
release profile observed for NTZ. For an inert hydrogel sys-
tem, diffusion is the major force for drug uptake [32]. The 
diffusion of the drug through the gel matrix into the sur-
rounding medium is controlled by the relaxation time of the 
polymeric chain, i.e. the time that the polymer takes to ex-
pand allowing the rapid diffusion of solute into the medium. 
The profile of the infrared spectra of hydrogels with and 
without nitrofurazone was maintained (see Fig. 3), which can 
mean that, probably, the interaction between NTZ and the 
polymer is not significative upon its incorporation into the 
hydrogel, and that it is just being carried by this hydrogel 
system. Thus, the release of NTZ into the medium was 
mainly influenced by the three-dimensional structure of the 
hydrogel and not by the crystal structure of nitrofurazone 
itself. 
 In studies involving thermogravimetric analyses (see Fig. 4), 
it has been observed that PVA exhibits two main regions of 
weight loss, 220-325ºC and 400-425ºC [33]. From inspection 
of the TGA analysis (see Fig. 4) plot of the hydrogel without 
 
 
Fig. (3). Infrared spectra and images of (a1 and a2, respectively) nitrofurazone (red line) compared with orcein dye (blue line, from data 
bank), infrared spectra and images of (b1 and b2, respectively) hydrogel without nitrofurazone (clPVA/Glut, red line) and hydrolyzed PVA 
(blue line, from the data bank), and infrared spectra and images of (c1 and c2, respectively) hydrogel with incorporated nitrofurazone 
(clPVA/Glut-NTZ, red line) and hydrolyzed PVA (blue line, from the data bank). [Processing parameters: Image (magnification, x36.0; 
width, 252.1 µm; height, 189.0 µm); experimental (analysis scans, 64; background scans, 64; resolution, a; spectral range, 4000.0-650.0; 
detector type, MCT; objective, 36X-ATR)]. 
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NTZ (clPVA/Glut, see Fig. 4a), one observes a similar ther-
mal behavior with 45.30% of weight loss at 328.5ºC and 
with 24.38% of weight loss at 421.4°C. For the hydrogel 
with incorporated NTZ (clPVA/Glut-NTZ, see Fig. 4b), sig-
nificative weight losses were observed at 144.4°C (24.3%) 
and at 342.5°C (19.74%) (see Fig. 4b). These results may 
indicate that addition of NTZ suggest the miscibility and 
interphase interaction between the components of hydrogel. 
This miscibility can be attributed to hydrogen bonding be-
tween hydroxyl groups of PVA and the protonated nitro 
groups of NTZ. 
 These changes are an indication that the mechanisms of 
thermal degradation reactions of the PVA hydrogel 
crosslinked with glutaraldehyde (see Fig. 4a) are altered 
when NTZ is incorporated into the polymeric film (see Fig-
ure 4b). Meanwhile, the loss of thermal stability observed 
(see Figs. 4a,b) does not imply instability of the product for 
the intended use. 
4. CONCLUSION 
 The optimized hydrogel developed in this research effort 
presented an adequate appearance with respect to color, 
transparency and flexibility. These characteristics promote 
the acceptance of the product by the end users (and/or pa-
tients) and, most likely, the ease of application in different 
regions of the human body. The hydrogel exhibited good 
characteristics with respect to release of the active principle 
(NTZ), which were duly verified through swelling assays, in 
vitro NTZ release rates and via performance of (pathogenic) 
 
 
Fig. (4). Thermogravimetric curves (TGA) of (a) plain hydrogel without NTZ (clPVA/Glut) and (b) of the hydrogel with incorporated NTZ 
(clPVA/Glut-NTZ). 
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bacterial susceptibility tests. The swelling tests indicated an 
increase in weight of 100±5% up to 350±11% without loss 
of the original form, during a timeframe of assay of 14 h. 
The incorporated NTZ presented (as expected, relative to its 
susceptibility profile) antimicrobial activity. Regarding the in 
vitro NTZ release rate, the results obtained were highly satis-
factory and pointed to a prolonged release of the drug. These 
characteristics may allow the use of the hydrogel in occlu-
sive dressings for prolonged periods of time. The physico-
chemical charaterization of the hydrogels indicated obtention 
of a product with adequate structural characteristics. Scan-
ning electron microscopy analyses allowed observation of a 
product with homogeneous morphology, and the infrared 
spectrophotometric analyses indicated that NTZ did not bind 
to the polymer in a way that would change its structure 
(which could reduce its antimicrobial activity). The thermal 
analyses have indicated that the hydrogel with incorporated 
NTZ may present extended thermal stability at the intended 
temperature of use (37ºC / body temperature). The ability of 
hydrogels to swell, under biological conditions, makes them 
an ideal material for use in drug delivery [34]. Due to their 
high water content, hydrogel creates a moist environment in 
the wound surface, which stimulates collagen synthesis and 
accelerates the growth and migration of epithelial cells. The 
hydrogel does not adhere to the wound surface and thus 
avoids the trauma during withdrawal [35]. Due to these rea-
sons, the major goal of the research effort undertaken in-
volved the development of a hydrogel with nitrofurazone as 
a thin film for wound treatment. From the results obtained in 
the research effort entertained herein, one may conclude that 
the hydrogel produced with NTZ presents promising charac-
teristics that allows its use in the treatment of skin lesions, 
especially for patients with wounds difficult to treat as is the 
case of ulcerations of the lower limbs of patients with Diabe-
tes mellitus. 
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